Author:
Murugan Suganya,Ashokan Agalya,Velmurugan Yogaswaran,Rajakannan Venkatachalam,Khamrang Themmila,Savaridasson Jose Kavitha,Subramanian Uma Maheshwari,Hemamalini Madhukar
Reference57 articles.
1. Design of novel PLK4 inhibitors as TRIM37-amplified breast cancer drugs using 3D-QSAR, molecular docking, and molecular dynamics simulation methods;Zhan;Molecular Simulation,2024
2. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective;Surget;Onco Targets Ther,2013
3. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells;Dandawate;Bioorg. Med. Chem. Lett.,2012
4. Synthesis, characterization and anticancer studies of Ni (II), Pd (II) and Pt (II) complexes with Schiff base derived from N-methylhydrazinecarbothioamide and 2-hydroxy-5-methoxy-3-nitrobenzaldehyde;Arafath MA;J Mol Struct,2017
5. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma;Ye;Neuropharmacology,2018